Building on Chiba and Hokkaido university research, Think-Lands is aiming to commercialise microneedles manufactured with its optical vortex production system.

The total raised by Oxford’s spinouts was down from $229m year-on-year, though university tech transfer office OUI also marked its largest ever single exit during the period.

Toyota, SoftBank and Denso have confirmed they have agreed to invest $1bn in Uber's autonomous driving spinoff at a $7.25bn post-money valuation.

Building on KU Leuven and Amsterdam UMC research, Cytura hopes to find small molecule candidates that combat the issue of genomic variability in cancer.

Global Wings plans to enhance its aviation services offering with the funding, which was supplied by two affiliates of Aviation Industry Corporation of China.

The gene therapy developer's latest round featured a $75m investment from Novartis and was closed as it withdrew its IPO application.

Talaris, previously known as Regenerex and based on research at University of Louisville, will use the funding to advance its cell therapy into later-stage clinical development.

Intel Capital took part in a series C round that boosted the wide area network technology developer's overall funding to almost $100m.

Celgene and Pfizer returned for small molecule drug developer Arrakis Therapeutics' latest round, which included GV and Wuxi AppTec Fund.

Osage University has returned for a $75m series B round raised by Arrakis Therapeutics, which has licensed technology from University of Pennsylvania.